Skip to main content
OpenTrials
Not yet recruiting

NCT Number: NCT07808593

Artificial Intelligence - Based Opportunistic Coronary Artery Calcium Scoring on Routine Chest-CT Scan

This retrospective, non-interventional study externally validates a pre-trained open-weight deep-learning algorithm (Swin-UNETR) for the opportunistic quantification of coronary artery calcium (CAC) on non-gated routine chest CT scans acquired at a German academic center, and evaluates the prognostic value of this automated imaging biomarker for cardiovascular risk stratification. Coronary calcium is an established predictor of cardiovascular risk, but is not routinely quantified on the tens of thousands of non-cardiac chest CTs performed each year. Because existing high-performing AI models were trained almost exclusively on U.S. cohorts, external validation on a European scanner fleet is required to exclude scanner bias (domain shift). The study comprises three linked analytic cohorts: (1) a validation cohort comparing the AI-CAC score against the ECG-gated cardiac CT Agatston reference; (2) a dialysis cohort assessing calcification progression and mortality; and (3) an emergency department cohort assessing short-term cardiovascular events. This is an investigator-initiated trial with no intervention on patients.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

About this study

The study analyzes a retrospective cohort of routine clinical CT examinations at University Hospital Cologne. Data originate from the hospital information system and Picture Archiving and Communication System (PACS) and are provided in pseudonymized form via the Medical Data Integration Center (MeDIC), acting as an independent trusted third party; the re-identification key remains under the sole control of MeDIC. Deep-learning inference is performed locally on isolated, access-controlled graphics processing unit (GPU) clusters of the institution (privacy by design / zero data retention); an open-weight model (Swin-UNETR) is used.

Three research questions are addressed in three analytic cohorts:

  • Validation (n ≈ 150): diagnostic agreement of the automatically extracted AI-CAC score (from the non-gated CT) with the reference Agatston score from a paired ECG-gated cardiac CT acquired within ≤ 12 months.
  • Dialysis (n ≈ 300): 150 hemodialysis patients plus 150 matched kidney-healthy controls with serial non-gated CTs; annualized calcification progression rate and all-cause mortality.
  • Emergency department (n ≈ 1,500): patients > 50 years with non-gated chest CTs from the Emergency Department (without a primary cardiac focus); occurrence of in-hospital major adverse cardiac event (MACE) or cardiovascular readmission within 12 months.

Extracted data include demographics (age at examination, sex), cardiovascular risk factors and comorbidities (ICD-10), long-term medication, laboratory values, examination metadata (date, scanner manufacturer, kilovolt peak (kVp), slice thickness), and outcome data (mortality, cardiovascular events, readmissions). Statistical analysis uses Spearman correlation, Cohen's kappa and Bland-Altman analysis for method comparison; t-test / Mann-Whitney-U for group differences in progression; and Kaplan-Meier (log-rank) plus multivariable Cox proportional-hazards and logistic regression for outcome prediction. Legal basis: § 6 (1) no. 2 Health Data Use Act of Germany (GDNG) in conjunction with Art. 9 (2) (j) and Art. 89 (1) GDPR (research privilege); no individual consent (disproportionate effort, Art. 14 (5) (b) GDPR). The AI (artificial intelligence) model carries no CE-marking and is used strictly as a research tool; AI-CAC scores are not systematically fed back into clinical care.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Validation cohort: patients with a paired non-gated chest CT and an ECG-gated cardiac CT acquired within ≤ 12 months.
  • Dialysis cohort: hemodialysis patients with serial non-gated CTs, plus matched kidney-healthy controls.
  • Emergency department cohort: patients > 50 years with non-gated chest CTs from the Emergency Department without a primary cardiac focus.

Exclusion criteria

  • Documented objection to the scientific use of the data pursuant to Art. 21 GDPR.
  • Cases lacking the minimum data required for analysis (insufficient image quality or missing reference/outcome data).

Treatment and study plan

Primary outcomes

  1. Diagnostic agreement of the AI-CAC score with the reference Agatston score

    Time frame: At the index non-contrast chest CT (Day 0) and at the paired ECG-gated cardiac CT obtained within 12 months after the index CT.

    Agreement between the automatically extracted AI-CAC score from the non-gated chest CT and the reference Agatston score from a paired ECG-gated cardiac CT, reported as Spearman correlation coefficient, Cohen's kappa across established risk classes (0, 1-100, 101-400, > 400), and Bland-Altman limits of agreement; supplemented by sensitivity, specificity, positive predictive value(PPV)/negative predictive value(NPV) and F1 score

  2. Annualized calcification progression rate and all-cause mortality

    Time frame: From the index non-contrast chest CT (Day 0) through the last available serial non-gated chest CT and the end of individual follow-up, up to 10 years per participant.

    Difference in the mean annual increase in AI-CAC between hemodialysis patients (dialysis cohort) and matched kidney-healthy controls measured on serial non-gated CTs (t-test / Mann-Whitney-U), and all-cause mortality analyzed by Kaplan-Meier (log-rank) and multivariable Cox proportional-hazards models (hazard ratios adjusted for confounders

  3. In-hospital Major Adverse Cardiac Event or cardiovascular readmission within 12 months (Emergency Department cohort).

    Time frame: 12 months after the index emergency department visit

    Occurrence of in-hospital Major Adverse Cardiovascular Events (myocardial infarction, stroke, resuscitation) or cardiovascular readmission within 12 months of the index Emergency Department visit, in relation to an unrecognized high AI calcium score (> 400); reported as adjusted odds ratios and hazard ratios from logistic regression and Cox models

Secondary outcomes

  1. Technical feasibility and inference time of the open-source AI model on local GPU clusters

    Time frame: At the index non-contrast chest CT (Day 0)

    Inference time per case and technical feasibility of running the open-weight deep-learning model (Swin-UNETR) as an isolated container on the institution's local GPU infrastructure

Study contacts

Contact information is provided by the study sponsor or research team.

Carsten Gietzen, MD

CONTACT

[email protected]

Cem Özel, MD

CONTACT

[email protected]

+49 176 2113 7580

Sponsors and collaborators

Lead sponsor

University of Cologne

Other

Collaborators

  • Institute for Diagnostic and Interventional Radiology, University Hospital Cologne
  • Medical Data Integration Center (MeDIC), University Hospital Cologne

Registry information

Official study title

Opportunistic Screening of Coronary Artery Calcium on Non-Gated Routine Chest CT Using Artificial Intelligence: Retrospective External Validation and Clinical Risk Stratification

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Sep 9, 2026
Registry last updated
Sep 9, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.